An initiation in Dáder methodology in the pharmacotherapeutic monitoring in a community pharmacy
Keywords:
Drug related problems, Drug therapy monitoring, Dáder Program, Community pharmacyAbstract
The objectives of this study were to analyse drug related problems (DRP) detected in patients at a community pharmacy,to classify them in accordance with the categories of necessity, effectiveness and safety, and to evaluate the communicationchannel used to solve the problem. The Dáder Program methodology for pharmacotherapy following at communitypharmacies, was proposed by the Research Group for Pharmaceutical Care at the University of Granada.A total of 44 DRPs were detected over a period of 16 months, of which 75% were successfully resolved. The distributionof DRPs in accordance with the three basic categories of drug therapy were as follows: indication 31.8% (DRP 1 & 2),effectiveness 34.1% (DRP 3 & 4) and safety 34.1% (DRP 5 & 6). A successful outcome was achieved in 72.4% of theDRPs when a physician was contacted in order to resolve the problem, while 66.7% of the cases were resolved successfullythrough direct pharmacist intervention with the patient. The main therapeutic groups predominating in DRPs were:antihypertensives, lipid-lowering drugs and antidiabetics. New strategies are necessary in order to overcome barriers andin so doing, increase the number of patients receiving pharmacotherapy following service. This may be achieved throughan improvement in communication techniques with the patient and a greater integration of the community pharmacywithin the health system.Downloads
References
Gastelurrutia MA. Morbilidad por medicamentos: ¿qué conocemos hoy?. El Farmacéutico 2002; 278: 42-51.
Tuneu L, García-Peláez M, López S, Serra G, Alba G, de Irala C, et al. Problemas relacionados con los medicamentos
en pacientes que visitan un servicio de urgencias. Pharm Care Esp 2000; 2: 177-192.
Otero MJ, Bajo A, Maderuelo JA, Domínguez-Gil A. Evitabilidad de los acontecimientos adversos inducidos por
medicamentos detectados en un Servicio de Urgencias. Rev Clin Esp 1999; 199: 796-805.
Baena MI, Fajardo P, Luque FM, Marín R, Arcos A, Zarzuelo A et al. Problemas relacionados con los medicamentos
en usuarios de un servicio de urgencias hospitalario: resultados de la validación de un cuestionario. Pharm Care Esp
; 3: 345-357.
Climente M, Quintana I, Martínez G, Atienza A, Jiménez NV. Prevalencia y características de la morbilidad relacionada
con los medicamentos como causa de ingreso hospitalario. Aten Farm 2001; 3 (1):9-22.
Martín MT, Codina C, Tuset M, Carné X, Nogué S, Ribas J. Problemas relacionados con la medicación como causa del
ingreso hospitalario. Med Clin (Barc) 2002; 118 (6): 205-210.
Álvarez de Toledo F, Arcos P, Eyaralar T, Abal F, Dago A, Cabiedes L et al. Atención Farmacéutica en personas que
han sufrido episodios coronarios agudos (estudio TOMCOR). Rev Esp Salud Pública 2001; 75:375-388.
Consenso sobre Atención Farmacéutica. Dirección General de Farmacia y Productos Sanitarios. Ministerio de Sanidad
y Consumo. 2001, Madrid.
Machuca M, Fernández-Llimós F, Faus MJ. Método Dáder. Guía de Seguimiento Farmacoterapéutico. Granada: GIAFUGR;
Comité de consenso. Segundo Consenso de Granada sobre problemas relacionados con medicamentos. Ars Pharmaceutica
; 43: 175-184.
García de Vicuña B. Barreras que impiden el desarrollo de la atención farmacéutica. El Farmacéutico 2002; 281:55-
Durán I, Martínez-Romero F, Faus MJ. ¿A qué población atendemos como farmacéuticos?, ¿cuáles son sus necesidades?.
Pharm Care Esp 1999; 1: 258-263.
Machuca M, Fernández-Llimós F. Respuestas sobre Atención Farmacéutica (Seguimiento del tratamiento farmacológico).
Barcelona: Saned; 2001.
Solá N. Martínez F. Curso 15. Sesiones clínicas en la metodología Dáder. El Farmacéutico 2002; 287: 50-55.
Armando PD, Semería N, Tenllado MI, Sola N. Programa Dáder en Argentina: Resultados del primer trimestre de
actividades. Pharm Care Esp 2001; 3: 196-203.
García M, García E, Tena M, Urbon A. Seguimiento farmacoterapéutico en las farmacias, por los Colegios Oficiales
de Farmacéuticos de Aragón (I): Implantación de la metodología Dáder (Seguimiento Farmacoterapéutico). Pharm
Care Esp 2002; 4: 231-241.
Martín MT, Tuset M, Codina C, Ribas J. Importancia de la patología secundaria a medicamentos. Inf Ter Sist Nac Salud
; 26(5): 128-132.
Durán I, Martínez Romero F, Faus MJ. Problemas relacionados con medicamentos resueltos en una farmacia comunitaria.
Pharm Care Esp 1999; 1:11-19.
Machuca M, Martínez Romero F, Faus MJ. Informe farmacéutico-médico según la metodología Dáder para el seguimiento
farmacológico. Pharm Care Esp 2000; 2: 358-363.
Herrera J. Objetivos de la atención farmacéutica. Aten Primaria 2002; 30(3): 183-187.
Downloads
Published
How to Cite
Issue
Section
License
The articles, which are published in this journal, are subject to the following terms in relation to the rights of patrimonial or exploitation:
- The authors will keep their copyright and guarantee to the journal the right of first publication of their work, which will be distributed with a Creative Commons BY-NC-SA 4.0 license that allows third parties to reuse the work whenever its author, quote the original source and do not make commercial use of it.
b. The authors may adopt other non-exclusive licensing agreements for the distribution of the published version of the work (e.g., deposit it in an institutional telematic file or publish it in a monographic volume) provided that the original source of its publication is indicated.
c. Authors are allowed and advised to disseminate their work through the Internet (e.g. in institutional repositories or on their website) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).
